These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31395145)

  • 1. Key Principles of Antiretroviral Pharmacology.
    Dionne B
    Infect Dis Clin North Am; 2019 Sep; 33(3):787-805. PubMed ID: 31395145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy: current drugs.
    Pau AK; George JM
    Infect Dis Clin North Am; 2014 Sep; 28(3):371-402. PubMed ID: 25151562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial Antiretroviral Therapy in an Integrase Inhibitor Era: Can We Do Better?
    Kelly SG; Masters MC; Taiwo BO
    Infect Dis Clin North Am; 2019 Sep; 33(3):681-692. PubMed ID: 31239093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beginning antiretroviral therapy for patients with HIV.
    Johnson JA; Sax PE
    Infect Dis Clin North Am; 2014 Sep; 28(3):421-38. PubMed ID: 25151564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inappropriate combinations of antiretroviral drugs].
    Machala L; Cerný R
    Klin Mikrobiol Infekc Lek; 2004 Oct; 10(5):241-3. PubMed ID: 15558454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study.
    Prosperi MC; Fabbiani M; Fanti I; Zaccarelli M; Colafigli M; Mondi A; D'Avino A; Borghetti A; Cauda R; Di Giambenedetto S
    BMC Infect Dis; 2012 Nov; 12():296. PubMed ID: 23145925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.
    Ciaffi L; Koulla-Shiro S; Sawadogo A; le Moing V; Eymard-Duvernay S; Izard S; Kouanfack C; Ngom Gueye NF; Fobang AA; Reynes J; Calmy A; Delaporte E;
    AIDS; 2015 Jul; 29(12):1473-81. PubMed ID: 26244387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update and review of antiretroviral therapy.
    Piacenti FJ
    Pharmacotherapy; 2006 Aug; 26(8):1111-33. PubMed ID: 16863488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral reduction: is it time to rethink the unthinkable?
    Colasanti J; Marconi VC; Taiwo B
    AIDS; 2014 Apr; 28(7):943-7. PubMed ID: 24401641
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral therapy: treatment-experienced individuals.
    Calvo KR; Daar ES
    Infect Dis Clin North Am; 2014 Sep; 28(3):439-56. PubMed ID: 25151565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin.
    Jørgensen S; Leth S; Sommerfelt M; Østergaard L; Tolstrup M; Søgaard OS
    AIDS; 2018 Jul; 32(12):1729-1731. PubMed ID: 30001247
    [No Abstract]   [Full Text] [Related]  

  • 12. Triple nucleoside reverse transcriptase inhibitor therapy in children.
    Handforth J; Sharland M
    Paediatr Drugs; 2004; 6(3):147-59. PubMed ID: 15170362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy.
    Simonetti FR; Ricaboni D; Cattaneo D; Micheli V; Rusconi S; Gervasoni C
    J Clin Virol; 2016 Jan; 74():75-7. PubMed ID: 26682615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe or life-threatening interactions between antiretrovirals and non-HIV drugs].
    Manzardo C; Tuset M; Miró JM; Gatell JM
    Enferm Infecc Microbiol Clin; 2015; 33(7):e15-30. PubMed ID: 24913990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire.
    Kroidl A; Ello F; Mgaya J; Lennemann T; Moh R; Maganga L; Eholie S; Pruvost A; Saathoff E; Girard PM; Zuhse R; von Massow F; Anglaret X; Hoelscher M; Danel C;
    AIDS; 2017 Feb; 31(4):501-509. PubMed ID: 27941394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the Frequencies of Contraindicated Drug-Drug Interactions Between Differing Antiretroviral Regimens in HIV-Infected Patients.
    Jakeman B; Nasiri M; Ruth L; Morse C; Mahatme S; Patel N
    Ann Pharmacother; 2017 May; 51(5):365-372. PubMed ID: 28367698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development.
    Smith JM; Flexner C
    AIDS; 2017 Jun; 31 Suppl 2():S173-S184. PubMed ID: 28471948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconception antiretroviral therapy and birth defects: what is needed?
    Bulterys M; Berry RJ; Watts DH
    AIDS; 2014 Nov; 28(18):2777-80. PubMed ID: 25493603
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral therapy 2006: pharmacology, applications, and special situations.
    Samuel R; Bettiker R; Suh B
    Arch Pharm Res; 2006 Jun; 29(6):431-58. PubMed ID: 16833010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin-antiretroviral interactions.
    Liedtke MD; Rathbun RC
    Ann Pharmacother; 2009 Feb; 43(2):322-8. PubMed ID: 19196837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.